Dual Microbubble Targeting System for Ultrasound Imaging Sensitivity
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Current targeted ultrasound contrast agents have low adhesion rates at target sites, limited sensitivity due to binding site availability, and high background noise from circulating untargeted agents, which restricts effective imaging and therapy, especially in deep tissues and under high-power imaging conditions.
Innovation Solution
A multi-modal targeting and therapeutic system involving sequentially deliverable pharmaceutical reagents, including a targeting agent, amplification agents, and imaging agents, which form a complex in situ to enhance binding and imaging sensitivity, and can be used for both imaging and therapeutic applications by increasing the number of microbubbles or vehicular agents at the target site.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Reliability
If targeted microbubbles are used for ultrasound imaging, then specificity to disease sites is improved, but adhesion rates remain low (10 microbubbles per microliter)
Solution Approach 1:
The targeting system is divided into multiple independent components: a targeting ligand attached to a first microbubble, and a second microbubble containing a binding site for the ligand. This segmentation allows each component to be optimized independently and enables the amplification effect where one targeting event can recruit multiple imaging microbubbles.
Solution Approach 2:
The patent implements a nested structure where the targeting ligand on the first microbubble binds to the second microbubble, creating a hierarchical assembly. This nested arrangement allows the targeting function and imaging function to be spatially organized, with the targeting event serving as the core that recruits additional imaging agents.
2Reliability
If one binding site on endothelial surface is used, then specific targeting is achieved, but only a single microbubble can bind per site
Solution Approach 1:
The system separates the targeting function (ligand on first microbubble) from the imaging function (second microbubble with binding site), allowing multiple imaging microbubbles to be recruited per binding site through the amplification mechanism.
Solution Approach 2:
The targeting ligand acts as an intermediary that bridges the endothelial binding site and multiple imaging microbubbles. The ligand on the first microbubble mediates the recruitment of multiple second microbubbles, amplifying the signal at each binding location.
3Measurement precision
If high power imaging is used, then imaging quality is improved, but microbubbles burst due to high peak negative pressures
Solution Approach 1:
The nested structure of the dual microbubble system provides mechanical stability. The first microbubble with the targeting ligand serves as a stable platform that recruits multiple second microbubbles, creating a more robust assembly that can withstand higher acoustic pressures without bursting.
Solution Approach 2:
The patent creates a composite microbubble system where two different microbubble types are combined. The first microbubble provides targeting stability while the second microbubble provides imaging capability, creating a composite structure with enhanced overall performance and stability under high power imaging conditions.
4Reliability
If sequential delivery of targeting agents is used, then binding specificity is improved, but background noise from circulating untargeted agents remains high
Solution Approach 1:
The patent implements preliminary action by first delivering the targeting ligand-bound microbubbles to bind to the disease site, then subsequently delivering the imaging microbubbles. This sequential approach allows unbound targeting agents to clear from circulation before the imaging step, reducing background noise.
Solution Approach 2:
The patent extracts the unbound circulating agents from the imaging process by using sequential delivery. The targeting phase is separated from the imaging phase, allowing clearance of unbound agents between steps and thereby removing the source of background noise.
Applied Scientific Principles
This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.
Function Achieved in This Case
Significantly improves imaging sensitivity and therapeutic efficacy by increasing the number of bound microbubbles, allowing for more efficient energy conversion to heat and localized therapy, while minimizing tissue damage, and enhancing imaging penetration and therapeutic effects such as hyperthermia and tissue ablation.
Implementation Method 1
the high peak negative pressures result in burst microbubbles
Implementation Method 2
detecting a signal produced by the imaging agent bound to the target site via the amplification agent
Data Source
AI summary
Compositions useful for target detection, imaging and treatment, as well as methods of production and use thereof, are disclosed herein.